Sanofi: failure of a phase 2 trial against ALS -February 16, 2024 at 10:00 am EST
Denali Therapeutics announced on Friday that it had been informed by its strategic partner Sanofi of the failure of a Phase 2 clinical trial in the treatment of amyotrophic lateral sclerosis...